Goodwill Amortization and Impairment Risk Associated with the Coleman Acquisition
First written in FY2022-Q3. 19 of 20 entries say "Materialised", first in FY2023-Q1. Latest entry: 2026-10-15.
VisasQ moved to the "Worse" side of this theme in 2022, 2 years before the typical company in this theme (2024).
The whole theme swung hardest in 2023: 35 of 97 companies on the "Worse" side.
54 other companies' latest entry also says "Materialised".
- FY2027-H1MaterialisedAnnual report
「Because the profitability of the fixed assets held by Coleman Research Group, Inc. had declined, the recoverable amount was deemed to be zero and the full carrying amount was recorded as an impairment loss. The impairment loss recorded for the interim period of the consolidated fiscal year was ¥128.029 million.」
An impairment loss of ¥128.029 million was recognized on Coleman’s fixed assets due to declining profitability, confirming the continued occurrence of impairment losses on acquisition-related assets. - FY2026MaterialisedAnnual report
「In light of the negative operating results and other factors of the tangible and intangible fixed assets recorded by consolidated subsidiary Coleman Research Group, Inc., their carrying amounts were reduced to recoverable amounts based on future cash flows and other factors, and an impairment loss of ¥254.135 million was recorded as an extraordinary loss.」
An impairment loss of ¥254.135 million was recognised on Coleman's property, plant and equipment and intangible assets against the backdrop of negative operating results. - 2026-05-08MaterialisedGeneral Meetings of Shareholders
「In light of the negative operating results and other factors of the tangible and intangible fixed assets recorded by consolidated subsidiary Coleman Research Group, Inc., their carrying amounts were reduced to recoverable amounts based on future cash flows and other factors, and an impairment loss of ¥254.135 million was recorded as an extraordinary loss.」
The company recorded a total impairment loss of ¥254.135 million on tools, furniture and fixtures and software held by Coleman Research Group, Inc. - FY2026-H1MaterialisedAnnual report
「Because the profitability of the property, plant and equipment held by Coleman Research Group, Inc. had declined, its recoverable amount was determined to be zero and the entire carrying amount was recognised as an impairment loss. The impairment loss recognised during the interim consolidated accounting period was ¥137.195 million.」
An impairment loss of ¥137.195 million was recognised on Coleman's property, plant and equipment due to declining profitability, and impairment of the acquisition-related assets has continued to materialise. - FY2025MaterialisedAnnual report
「In light of the negative operating results generated by the consolidated subsidiary Coleman Research Group, Inc., the carrying amounts of its property, plant and equipment and intangible assets were reduced to their recoverable amounts based on future cash flows and other factors, and an impairment loss of ¥398.955 million was recognised as an extraordinary loss.」
Against the backdrop of Coleman's negative operating results, an additional impairment loss of ¥398.955 million was recognised on property, plant and equipment and intangible assets. - FY2025-H1MaterialisedAnnual report
「Because the profitability of the property, plant and equipment held by Coleman Research Group, Inc. had declined, its recoverable amount was determined to be zero and the entire carrying amount was recognised as an impairment loss. The impairment loss recognised during the interim consolidated accounting period was ¥263.453 million.」
An impairment loss of ¥263.453 million was recognised on property, plant and equipment held by Coleman, with the recoverable amount set at zero due to declining profitability. The impairment risk associated with the acquisition-related assets has continued to materialise. - FY2025-Q1MaterialisedAnnual report
「Because the profitability of the property, plant and equipment held by Coleman Research Group, Inc. had declined, its recoverable amount was determined to be zero and the entire carrying amount was recognised as an impairment loss. The impairment loss recognised during the three-month period ended the first quarter was ¥195.444 million.」
An impairment loss of ¥195.444 million was recognised on Coleman's property, plant and equipment, with the recoverable amount set at zero due to declining profitability. The impairment risk associated with the acquisition-related assets has continued to materialise. - FY2024-Q3MaterialisedAnnual report
「Depreciation and amortisation ¥598.176 million Goodwill amortisation ¥329.22 million」
The amortisation burden for intangible assets and goodwill associated with the Coleman acquisition continued, with depreciation and amortisation of ¥598.176 million and goodwill amortisation of ¥329.22 million recognised for the nine-month period ended the third quarter. - FY2024-Q2MaterialisedAnnual report
「The main components were a loss before income taxes of ¥146.58 million, total depreciation and goodwill amortisation recognised of ¥600.309 million, an increase in trade receivables of ¥132.195 million, an increase in contract liabilities of ¥126.344 million, a decrease in consumption taxes payable and other items of ¥112.815 million, and income taxes paid of ¥281.436 million, among other items.」
Depreciation and amortisation, including goodwill amortisation associated with the Coleman acquisition, continued to be recognised, with total depreciation and goodwill amortisation for the six-month period ended the second quarter amounting to ¥600.309 million. - FY2024-Q1MaterialisedAnnual report
「Depreciation and amortisation ¥185.736 million; goodwill amortisation ¥105.155 million」
The goodwill amortisation burden associated with the Coleman acquisition was recognised in the first quarter as well, with goodwill amortisation amounting to ¥105.155 million. - FY2023-Q3MaterialisedAnnual report
「Depreciation and amortisation ¥509.781 million Goodwill amortisation ¥305.239 million」
The amortisation burden for intangible assets and goodwill associated with the Coleman acquisition continued, with depreciation and amortisation of ¥509.781 million and goodwill amortisation of ¥305.239 million recognised for the nine-month period ended the third quarter. - FY2023-Q2MaterialisedAnnual report
「Net cash provided by operating activities was ¥536.763 million. The main components were profit before income taxes of ¥105.819 million, total depreciation and goodwill amortisation recognised of ¥516.96 million, a decrease in the provision for bonuses of ¥130.2 million, a decrease in trade receivables of ¥221.571 million, and an increase in advances received of ¥251.587 million, among other items.」
The amortisation burden for goodwill and other assets associated with the Coleman acquisition continued, with total depreciation and goodwill amortisation of ¥516.96 million recognised as an adjustment to operating cash flow. - FY2023-Q1MaterialisedAnnual report
「In addition, the results of Coleman Research Group, Inc., acquired in November 2021, have been consolidated, resulting in the recognition of amortisation of goodwill and other intangible assets, among other items.」
Amortisation of goodwill and other intangible assets associated with the acquisition was actually recognised, with goodwill amortisation amounting to ¥92.33 million in the first quarter. The post-acquisition amortisation burden has become apparent. - FY2022-Q3First statedAnnual report
「Before the acquisition, we conducted a detailed investigation of the company's financial position, contractual relationships and other matters, including with the assistance of third-party advisers. However, amortisation of goodwill may temporarily reduce the Group's operating results. In addition, if the post-acquisition business plan fails to progress as planned, impairment of goodwill may become necessary, which could affect the Group's operating results and financial position.」
The Coleman acquisition generated ¥10,313 million in goodwill, with amortisation and impairment if the business plan is not achieved described as new, specific risks.